Image

Prehabilitation to Patients With Prostate Cancer

Prehabilitation to Patients With Prostate Cancer

Recruiting
18 years and older
Male
Phase N/A

Powered by AI

Overview

The goal of this feasibility study is to test a newly developed, multicomponent prehabilitation intervention to patients with prostate cancer, to improve their resilience to treatment side-effects. The main questions it aims to answer are:

  • Are patients and their close relatives willing to take part in prehabilitation?
  • What is the acceptability and feasibility of the prehabilitation intervention, seen from the perspectives of patients, their close relatives, and healthcare professionals?
  • Are the planned data collection methods feasible, and are there indications of a clinical effect?

Participants will:

  • Take part in 12 weeks of physical exercise training
  • Attend a 4-day residential prehabilitation intervention, where they receive education and do exercises. After 12 weeks, it is possible to take part in a voluntary follow-up session.
  • Patients will respond to questionnaires about their health, symptoms, and quality of life. Patients and their close relatives will attend a group interview. Patients will also complete an exercise diary and brief physical tests

Eligibility

Inclusion Criteria:

  • Diagnosed with prostate cancer
  • min 18 years old
  • Treatment: Androgen deprivation therapy and raditation therapy
  • Resident in Vejle Municipality or Esbjerg Municipality
  • Can take part in residential prehabiliation in week 43 or 50, 2025, as well as physical exsercise training in the municipality
  • Willing to take part in a research study
  • Suited to take part in group sessions
  • Be able to read and be understood in Danish
  • Be responsible for own personal hygiene and medications at the 4-day residential stay

Exclusion Criteria:

  • Persons who do not fulfil the inclusion criteria will be excluded

Study details
    Prostate Cancer (Diagnosis)

NCT07162987

Odense University Hospital

16 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.